We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03053466
Previous Study | Return to List | Next Study

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03053466
Recruitment Status : Completed
First Posted : February 15, 2017
Last Update Posted : May 9, 2022
Novotech (Australia) Pty Limited
Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.)
Information provided by (Responsible Party):
Apollomics (Australia) Pty. Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 25, 2022
Actual Study Completion Date : February 25, 2022